NASA's Artemis II Mission to Conduct Critical Health and Lunar Studies
NASA's Artemis II mission will carry astronauts on a lunar flyby to conduct experiments on human health and lunar observations, informing future deep-space missions.
NASA's Artemis II mission is set to launch today, April 1, 2026, at 6:24 p.m. EDT from Kennedy Space Center in Florida. This 10-day mission will carry astronauts Reid Wiseman, Victor Glover, Christina Koch, and Canadian Space Agency astronaut Jeremy Hansen aboard the Orion spacecraft on a lunar flyby, marking the first human journey to the Moon's vicinity in over 50 years.
Beyond testing deep-space hardware, Artemis II aims to gather critical data on human health and performance in space. The crew will participate in several experiments, including the AVATAR study, which uses lab-grown tissue models to assess bone marrow's response to space radiation. Additionally, the ARCHeR study will monitor astronauts' stress levels, movement, sleep, and cognitive performance using wrist-mounted devices. These investigations will help develop personalized healthcare strategies for future long-duration missions.
The mission will also focus on radiation exposure. Astronauts will carry personal dosimeters to track real-time exposure, complemented by six radiation sensors installed throughout the Orion crew module. This data will enhance understanding of radiation's impact on human health during deep-space travel.
As Orion arcs around the Moon's far side, the crew will observe and photograph lunar terrain, including regions like the Orientale Basin, a massive impact scar marking the boundary between the Moon's near and far sides. These observations will provide valuable insights into lunar geology and inform future exploration missions.
Artemis II represents a significant step in NASA's Artemis program, laying the groundwork for sustained human exploration of the Moon and eventual missions to Mars.